Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiangyu Ling
Observed name:
Ling, Xiangyu
Institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Jiangsu Province Hospital,
Nanjing Medical University
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0009-0005-2938-4065
Observed ORCID:
0009-0005-2938-4065
OpenAlex ID:
A5100596176
LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation
2025
·
Litao Liang
, Wenbo Jia
, et al.
·
Molecular Medicine
·
11
Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8 + T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma
2025
·
Wenbo Jia
, Jinyi Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
·
9
PDF
Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis
2024
·
Yanzhi Feng
, Litao Liang
, et al.
·
Journal of Hepatocellular Carcinoma
·
7
PDF
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
2025
·
Chao Xu
, Litao Liang
, et al.
·
Cancer Cell International
·
5
PDF
GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13
2025
·
Litao Liang
, Chao Xu
, et al.
·
Acta Biochimica et Biophysica Sinica
·
3
The deficiency of ALKBH5 promotes lenvatinib resistance and CD8+ T cell exhaustion via accumulation of the cholesterol metabolite 27HC in hepatocellular carcinoma
2026
·
Jinyi Wang
, Wenbo Jia
, et al.
·
Cancer Letters
·
2
TTC36-Mediated Tumor Suppression via YBX3/SPRED1 Axis Paradoxically Reduces Sorafenib Sensitivity in Hepatocellular Carcinoma
2025
·
Wenhu Zhao
, Xiangyu Ling
, et al.
·
International Journal of Biological Sciences
·
2
CircCOPA promotes hepatocellular carcinoma progression through the HNRNPD/SPRED2 axis-mediated activation of ERK/MAPK signaling pathway
2026
·
Lianbao Kong
, Zhiwen Feng
, et al.
·
Research Square
PDF
Corrigendum to “The deficiency of ALKBH5 promotes lenvatinib resistance and CD8+ T cell exhaustion via accumulation of the cholesterol metabolite 27HC in hepatocellular carcinoma” [643 10 (2026) 218316]
2026
·
Jinyi Wang
, Wenbo Jia
, et al.
·
Cancer Letters
The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Xiangyu Ling
, Wenhu Zhao
, et al.
·
Journal of Translational Medicine
Additional file 5 of The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
Additional file 1 of The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
Additional file 2 of The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
Additional file 4 of The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
Additional file 3 of The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
2026
·
Ling, Xiangyu
, Zhao, Wenhu
, et al.
·
Figshare
Show more works
View as search
Works count:
22
Citation count:
39
H-index:
4
I10-index:
1
Year
Topic
Type
